ACVS

PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN INDIANAPOLIS, INDIANA

Retrieved on: 
星期一, 四月 8, 2024

PetVivo intends to exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology.

Key Points: 
  • PetVivo intends to exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology.
  • Spryng is an intra-articular injectable veterinary medical device composed of sterilized, extra-cellular matrix microparticles.
  • Such action promotes the restoration of proper joint mechanics, thereby aiding in the management of noninfectious sources of joint pain such as joint instability, degenerative joint disease and osteoarthritis.
  • For more information about PetVivo Holdings, Inc. please contact [email protected] or visit https://petvivo.com/
    Pain Management Forum Exhibit Details:
    Location: The JW Marriott in Indianapolis, Indiana
    Presentation Title: How do we Elevate Our Strategy for Managing Osteoarthritis in Pets?

PetVivo Holdings, Inc. to Exhibit at American Association of Equine Practitioners Conference in San Diego, California

Retrieved on: 
星期二, 十一月 21, 2023

PetVivo will exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology, a medical device injection of sterilized, extra-cellular matrix microparticles that are lubricious and spongy used in the treatment of lameness and other joint related afflictions, such as osteoarthritis.

Key Points: 
  • PetVivo will exhibit its lead product, SPRYNG™ with OsteoCushion™ Technology, a medical device injection of sterilized, extra-cellular matrix microparticles that are lubricious and spongy used in the treatment of lameness and other joint related afflictions, such as osteoarthritis.
  • The AAEP is the largest veterinary equine conference that services the United States, and normally plays host to more than 5,000 participants including many of the top industry professionals.
  • If you would like to attend the presentations by Dr. Yarbrough and Dr. Manning the details are provided below.
  • Location: San Diego Convention Center in San Diego, California
    For more information about PetVivo Holdings, Inc. and its innovative product, Spryng, please contact [email protected] or visit https://petvivo.com/ and https://sprynghealth.com/ .

PetVivo Holdings, Inc. Announces Scheduled Presentations by PetVivo Veterinarians at the American Association of Equine Practitioners Convention in San Diego, California

Retrieved on: 
星期四, 十一月 2, 2023

Tom Yarbrough, DVM, ACVS, the Director of Product Research for PetVivo Holdings Inc., is providing a presentation entitled “Modern Wild West: Navigating the new classes of joint therapeutics”.

Key Points: 
  • Tom Yarbrough, DVM, ACVS, the Director of Product Research for PetVivo Holdings Inc., is providing a presentation entitled “Modern Wild West: Navigating the new classes of joint therapeutics”.
  • In addition, Joseph Manning, DVM, MBA, Senior Technical Veterinarian for PetVivo Holdings, inc., will be discussing the use of Spryng™ with OsteoCushion™ Technology in a presentation entitled “Advancements in Intra-Articular Therapies: Experiences with a novel collagen-elastin hydrogel microparticles (CEHM) biomaterial used intra-articularly for joint conditions in equines”.
  • If you would like to attend the presentations by Dr. Yarbrough and Dr. Manning the details are provided below.
  • PetVivo’s innovative product, SPRYNG™ with OsteoCushion™ Technology, is an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles; Spryng microparticles perform in the joint as wet, slippery micro-cushions used in the management of lameness and other joint related afflictions, such as osteoarthritis.

CORRECTION/RETRACTION: New to The Street Announces Four Corporate Interviews on its 525th Show, Airing on the Fox Business Network, Monday, October 30, 2023, at 10:30 PM PT

Retrieved on: 
星期五, 十月 27, 2023

New to The Street’s 525th TV episode features the following four (4) Companies and their representatives:

Key Points: 
  • New to The Street’s 525th TV episode features the following four (4) Companies and their representatives:
    1).
  • The study demonstrated the efficacy of Spryng as an excellent, non-invasive alternative in treating dogs with cranial cruciate disease and injuries.
  • John believes as more published studies prove the viability of Spryng more veterinarians will adopt it as a front-line treatment.
  • PETV's Spryng is becoming more widely known as an effective disruptive technology for treating dogs, horses, and cats with osteoarthritis.

New to The Street Announces Five Corporate Interviews on its 525th Show, Airing on the Fox Business Network, Monday, October 30, 2023, at 10:30 PM PT

Retrieved on: 
星期五, 十月 27, 2023

Gold/Silver Mining – Lahontan Gold Corp.'s (OTCQB: LGCXF) (TSXV: LG) ($LGCXF) interview with Kimberly Ann, Founder, CEO, President, and Director.

Key Points: 
  • Gold/Silver Mining – Lahontan Gold Corp.'s (OTCQB: LGCXF) (TSXV: LG) ($LGCXF) interview with Kimberly Ann, Founder, CEO, President, and Director.
  • The study demonstrated the efficacy of Spryng as an excellent, non-invasive alternative in treating dogs with cranial cruciate disease and injuries.
  • Spryng is a naturally derived matrix of building proteins that mimics collagen tissue, significantly improving animals with cruciate damage and disease.
  • John believes as more published studies prove the viability of Spryng more veterinarians will adopt it as a front-line treatment.

PetVivo Holdings, Inc. Encouraged Over Positive Response Received at 2023 American College of Veterinary Surgeons Conference

Retrieved on: 
星期三, 十月 25, 2023

Two presentations at the ACVS Conference heightened the enthusiastic interest in veterinarians to learn more about Spryng and consider its use in their practices.

Key Points: 
  • Two presentations at the ACVS Conference heightened the enthusiastic interest in veterinarians to learn more about Spryng and consider its use in their practices.
  • Spryng™ with OsteoCushion™ Technology) into the stifle joint of dogs with suspected cruciate ligament rupture.
  • Dr. Erik Kleeman, DVM presented the clinical study poster at the ACVS Conference.
  • In summary, this study demonstrated that Spryng™ is a reasonable, non-invasive alternative for patients with cranial cruciate disease (“CCD”) when patient and/or owner factors preclude surgical intervention.

New to The Street Announces Six Business Interviews on its 524th Show, Airing on the Fox Business Network, Monday, October 23, 2023, at 10:30 PM PT

Retrieved on: 
星期五, 十月 20, 2023

New to The Street's 524th TV episode line-up features the following six (6) business interviews:

Key Points: 
  • New to The Street's 524th TV episode line-up features the following six (6) business interviews:
    1).
  • Pet Health – PetVivo Holdings, Inc.'s (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV) interview with John Lai, CEO/President.
  • Space Travel Medicines - Vector Space Biosciences, Inc.'s ( SBIO ) interview with Kasian Franks, CEO and Co-Founder.
  • Management expects to move forward with Phase 3 clinical trials with the expectation of an FDA approval in 2026.

PetVivo Holdings, Inc. Announces Presentation of Clinical Study Results at the American College of Veterinary Surgeons Conference in Louisville, Kentucky

Retrieved on: 
星期四, 十月 12, 2023

Spryng™ with OsteoCushion™ Technology) into the stifle joint of dogs with suspected cruciate ligament rupture.

Key Points: 
  • Spryng™ with OsteoCushion™ Technology) into the stifle joint of dogs with suspected cruciate ligament rupture.
  • Dr. Erik Kleeman, DVM will be presenting the poster at ACVS.
  • There were significant improvements in all of the primary and secondary clinical variables throughout the study period (pain, lameness, quality of life scoring).
  • To view the poster presentation and a video interview of Dr. Kleeman discussing the clinical study presented at the ACVS annual conference please visit the following:

PetVivo Holdings, Inc. to Exhibit at 2023 American College of Veterinary Surgeons Conference

Retrieved on: 
星期二, 十月 10, 2023

If you would like to attend the presentation by Dr. Rychel and Dr.Fry the details are provided below.

Key Points: 
  • If you would like to attend the presentation by Dr. Rychel and Dr.Fry the details are provided below.
  • If you would like to attend the presentation by Dr. Manning the details are provided below.
  • For more information about PetVivo Holdings, Inc. and its innovative product, Spryng, please contact [email protected] or visit https://petvivo.com/ and https://sprynghealth.com/ .
  • Location: Kentucky International Convention Center: Exhibit Hall B in Louisville, Kentucky
    Dr. Jessica Rychel and Lindsey Fry Presentation Schedule: